<DOC>
	<DOCNO>NCT02437838</DOCNO>
	<brief_summary>The primary objective study examine whether augmented renal clearance ( ARC ) compromise renally eliminate drug therapeutic serum concentration patient traumatic brain injury ( TBI ) estimate optimal dose need achieve therapeutic serum concentration probe medication levetiracetam patient TBI .</brief_summary>
	<brief_title>Optimizing Drug Doses Critically Ill</brief_title>
	<detailed_description>Purpose : The primary objective study examine whether augmented renal clearance compromise renally eliminate drug therapeutic serum concentration patient traumatic brain injury ( TBI ) estimate optimal dose need achieve therapeutic serum concentration probe medication levetiracetam patient TBI . Participants : The population comprise patient traumatic brain injury require levetiracetam seizure prophylaxis admit neuroscience intensive care unit Procedures ( method ) : This multi-center , prospective , non-randomized pharmacokinetic study patient TBI . In patient meet inclusion criterion , 12-hour urine collection measure creatinine clearance levetiracetam urine concentration perform daily 7 day . Serum levetiracetam concentration obtain twice daily 7 day .</detailed_description>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<criteria>1 . Adults â‰¥ 18 year 2 . Patients TBI require levetiracetam seizure prophylaxis 3 . Anticipated length stay SICU NSICU &gt; 48 hour 4 . Informed consent provide patient 's designated medical proxy 1 . Pregnancy 2 . Patients renal dysfunction ( CKD stag 3 5 and/or SCr &gt; 1.4 mg/dL ) 3 . Patients receive renal replacement therapy 4 . Brain death suspect imminent brain death within next 48 hour 5 . Patients history nephrectomy renal transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>